Patent ID: 11896593
Assignee: BIO-PHARM SOLUTIONS CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method for treating a psychiatric disorder in a subject, comprising:
selecting a subject having a psychiatric disorder; and
administering to the subject a pharmaceutical composition comprising a sulfamate derivative compound of Chemical Formula I or a pharmaceutically acceptable salt thereof:, , wherein
R1 and R2 are each independently selected from the group consisting of hydrogen, C1-C5 alkyl, C2-C5 alkenyl and C6-C10 aryl, R1 and R2 together with the carbon atom to which they attach form a C3-C12 cycloalkyl group, or R1 and R2 are bond and they together with the oxygen atom to which they attach form a carbonyl group;
A is an aryl moiety or a heterocyclic moiety optionally substituted by one or more substituents selected from the group consisting of hydrogen, hydroxyl, C1-C5 alkoxy, C1-C5 alkyl, C2-C5 alkenyl, C6-C10 aryl, C1-C5 alkoxycarbonyl, carboxyl, C2-C5 acyl, C1-C5 alkylthio, cyano, nitro, amine, C1-C5 alkylamine and halogen;
R3 and R4 are each independently hydrogen or C1-C3 alkyl;
l and m are each independently an integer of 0˜4; and
the psychiatric disorder is selected from the group consisting of anxiety disorder, mood disorder, somatoform disorder, dissociative disorder, psychotic disorder, personality disorder, sexual disorder, sexual identity disorder, substance-related disorder, eating disorder, sleep disorder, impulse control disorder and adjustment disorder.